Technical Analysis for IMUX - Immunic, Inc.

Grade Last Price % Change Price Change
grade B 14.46 2.55% 0.36
IMUX closed up 2.55 percent on Wednesday, August 21, 2019, on 9 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical IMUX trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish 2.55%

Older signals for IMUX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Immunic, Inc. (Nasdaq:IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products: IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORγt; and IMU-856 targets the restoration of the intestinal barrier function. Immunic's lead development program, IMU-838, is in phase 2 clinical development for ulcerative colitis and relapsing-remitting multiple sclerosis, with an additional phase 2 trial in Crohn's disease planned for 2019. An investigator-sponsored proof-of-concept clinical trial for IMU-838 in primary sclerosing cholangitis is planned to start at the Mayo Clinic.
Medicine Biopharmaceutical Medical Specialties Clinical Medicine Immunotherapy Autoimmune Diseases Multiple Sclerosis Psoriasis Ulcerative Colitis Abdominal Pain Crohn's Disease Relapsing Remitting Multiple Sclerosis Mayo Clinic
Is IMUX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 360.0
52 Week Low 6.0
Average Volume 178,140
200-Day Moving Average 11.4013
50-Day Moving Average 12.5074
20-Day Moving Average 13.3905
10-Day Moving Average 13.529
Average True Range 1.1199
ADX 27.76
+DI 22.858
-DI 13.771
Chandelier Exit (Long, 3 ATRs ) 11.3753
Chandelier Exit (Short, 3 ATRs ) 15.4797
Upper Bollinger Band 14.3859
Lower Bollinger Band 12.3951
Percent B (%b) 1.04
BandWidth 14.867257
MACD Line 0.3626
MACD Signal Line 0.2954
MACD Histogram 0.0672
Fundamentals Value
Market Cap 610.32 Million
Num Shares 42.2 Million
EPS -1.35
Price-to-Earnings (P/E) Ratio -10.71
Price-to-Sales 0.00
Price-to-Book 3.02
PEG Ratio -0.27
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.41
Resistance 3 (R3) 15.30 14.88 15.25
Resistance 2 (R2) 14.88 14.64 14.93 15.20
Resistance 1 (R1) 14.67 14.49 14.78 14.78 15.14
Pivot Point 14.25 14.25 14.30 14.30 14.25
Support 1 (S1) 14.04 14.01 14.14 14.14 13.78
Support 2 (S2) 13.62 13.86 13.67 13.72
Support 3 (S3) 13.41 13.62 13.67
Support 4 (S4) 13.51